acetyl intermedi may reach critic inflect
point capac util come next
year lean direct
tough comp regardless key question pay
retain equal-weight rate rais price target
larg reflect materi step acetyl intermedi ebitda
versu expect also first evalu post
recent abandon acet tow jv blackston announc last june see
recent note see transact panacea acet tow
produc see gateway get acet tow
portfolio therefor refocu investor attract growth stori
engin materi em view equiti market
overli discount potenti acet tow jv term bake
cash proce would receiv well assum would lead
materi improv acet tow overtim anticip neg
rerat deal go correct howev
last long stori alreadi chang better acetyl
intermedi ai upsid driven increas ep growth
month year
time dust acet acid vinyl acet monom model
updat number year equiti narr quickli shift
get acet tow similar jv ai em
remain co rather equiti narr like becom potenti
super-cycl progress ai would want monet earli
cycl particular indic ai work way
low perhap even lower time capac util rate acet
acid back low mean asset unplan
downtim common themat commod chemic instant util rate
move way provid lot price power
process narr chines capac like declin
environment reform demand continu steadili increas
modest pace like push us toward key break point util
chemic unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
rate distant futur ceo mark rohr remind investor today
acet acid use regularli trade versu global week rang
ai thesi credibl go spruce model
come formal opinion meantim lean direct simpli
ingredi seem familiar seen commod
chemic chain recent year unanticip signific margin flare up result
confluenc oversuppli low margin creat neglect industri
new capac perspect ii consist modest growth plu suppli side
reform sudden tighten market without mani see come iii
exist asset run well number reason said
extraordinari result certainli seem like tall order ahead
grow indic
key question pay clearli commod busi commod
busi begin cycl peopl pay
opposit celanes current trade ebitda forecast
back em ai acet tow yield
price-to-earnings ratio ebitda em seem reason given
organ inorgan volum growth trend though margin degrad
confluenc raw materi increas lower margin bolt-on curb enthusiasm
bit would also line see similar busi within dowdupont
basf acet tow product secular declin consolid
way rule eu ai seem reason well given solid
cash flow characterist also relev commod comp lyondellbasel
methanex trade ai realli growth upsw like case
higher multipl today account signific cash flow gener
tomorrow present see market risk adjust evalu new celanes
equiti thesi sensibl thu rais price target
hope back detail thought distant
part model impli ebitda incl equiti incom
ai cycl em innov tow capac acetyl intermedi cycl
acceler caus multipl expans ahead new higher base level
ebtida innov em drive price off-set raw materi cost
increas acet tow capac reduct provid optim price
ai margin achiev signific step chang debat continu
direct em growth bolt-on expect acet tow
manag neg bias
ai mean revert global asset run well demand declin raw materi
flatten cost curv em innov off-set weak auto build
pressur competit offer acet tow price continu move
lower competit pressur intensifi demand fall due heat-not-
equiti market long attract
growth engin materi
continu play ahead expect
new wrinkl stori whether
commod orient acetyl intermedi
cusp meaning multi-year
cycl lean direct present
expect debat remain given challeng
comp go forward question
acet tow industri oversuppli
need capac ration end
decad pose risk heat-not-
acet acid profit tie global
cost curv occupi low-
cost posit industri profit tie
margin produc china
take capac offlin due environment
reform capac util recent
cross back case
move toward near futur
segment auto current
provid oem health care compani
other applic improv product
perform lower cost versu
risk achiev price
slowdown auto product
slowdown europe/asia
declin cigarett consumpt
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report vincent
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
import us regulatori disclosur subject compani
